Search
for
Sort by
Research 91–120 of 631
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Molecular Dissection of Mesenchymal–Epithelial Interactions in the Hair Follicle
- Is dehydroepiandrosterone a hormone?
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- Identification of the cell lineage at the origin of basal cell carcinoma
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- Recent advances in electrospun nanofibers for wound healing
- Bioavailability of Albumin-Bound Testosterone†
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- EEMCO Guidance for the in vivo Assessment of Skin Greasiness
- Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil
- Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Baiting Proteins with C<sub>60</sub>
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- 9 Role of 5α-reductase in health and disease
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Biomaterials for in situ tissue regeneration: development and perspectives
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Anti-androgenic activities of Ganoderma lucidum
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Primary cicatricial alopecia
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum